Kimberly-Clark to Acquire Kenvue in $48.7bn Deal
Kimberly-Clark is set to acquire Kenvue in a cash and stock transaction valuing Kenvue at about $48.7 billion.
The transaction would create a company that includes brands such as Kleenex, Huggies, Band-Aid, as well as Tylenol, which has been embattled due to claims by Donald Trump that it increases the risk of autism in children when used by pregnant women.
Mike Hsu, Chairman and CEO of Kimberly-Clark, said the transaction would create “a global health and wellness leader”.
Kenvue is described as being “uniquely positioned at the intersection of CPG and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health categories”.
- Shares of Kenvue have risen 17 per cent since the announcement.
- Kimberly-Clark shares dropped 12 per cent.
- Current Kimberly-Clark shareholders will own about 54 per cent of the combined company after completion.
- Kenvue shareholders will hold roughly 46 per cent.
Completion is expected in the second half of 2026.
Author's summary: Kimberly-Clark acquires Kenvue for $48.7bn.
More News
- Live updates: Yukon Liberal leader Mike Pemberton unlikely to secure seat
- After 7% vote early, polls open 7 a.m.-7 p.m. Tuesday for Bulloch County’s other 49,900 voters
- Toys for Tots 2025 kicks off Thursday at Visit Statesboro
- Jake Paul- Gervonta Davis Officially Cancelled | BoxingInsider.com Promotions
- An Idaho rancher lives with his cattle in wolf country. Can Colorado ranchers do the same?
- Keep Statesboro-Bulloch Beautiful hosts 4th annual Recycle Fest
- Live updates: Yukon Liberal leader Mike Pemberton unlikely to secure seat
- Men’s Basketball: Florida Atlantic bounces back in overtime thriller, 83-78